Micro-k and Intervertebral disc protrusion - a phase IV clinical study of FDA data

Summary:

Intervertebral disc protrusion is reported as a side effect among people who take Micro-k (potassium chloride), especially for people who are male, 50-59 old, also take Gabapentin, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Intervertebral disc protrusion when taking Micro-k. It is created by eHealthMe based on reports of 1,874 people who have side effects when taking Micro-k from the FDA, and is updated regularly.

What is Micro-k?

Micro-k has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 1,895 Micro-k users. Check the latest studies of Micro-k.

What is Intervertebral disc protrusion?

Intervertebral disc protrusion (spinal disc protrusion) is found to be associated with 1,531 drugs and 1,305 conditions by eHealthMe. Check the latest studies of Intervertebral disc protrusion.

On Jul, 04, 2026

1,874 people reported to have side effects when taking Micro-k.
Among them, 35 people (1.87%) have Intervertebral disc protrusion.

Could Micro-k cause Intervertebral disc protrusion?

Among these 35 people:

What is the gender of people who have Intervertebral disc protrusion when taking Micro-k? *

female: 42.86 %
male: 57.14 %

What is the age of people who have Intervertebral disc protrusion when taking Micro-k? *

What are other drugs people take besides Micro-k? *

What are other side effects people have besides Intervertebral disc protrusion? *

Pain: 29 people, 82.86%
Stress And Anxiety: 26 people, 74.29%
Joint Pain: 24 people, 68.57%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 23 people, 65.71%
Intervertebral Disc Degeneration (spinal disc degeneration): 22 people, 62.86%
Enlarged Heart: 21 people, 60.00%
Osteonecrosis Of Jaw (death of bone of jaw): 20 people, 57.14%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 20 people, 57.14%
Acute Kidney Failure: 19 people, 54.29%
Depression: 18 people, 51.43%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 21 people, 60.00%
Heart Rate Irregular: 6 people, 17.14%
High Blood Cholesterol: 4 people, 11.43%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 8.57%
Indigestion: 2 people, 5.71%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 5.71%
Gastric Ph Decreased: 2 people, 5.71%
Heart Rate Increased: 2 people, 5.71%
Hypersensitivity: 2 people, 5.71%
Meniere's Disease (a disorder of the inner ear that can affect hearing and balance to a varying degree): 2 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Micro-k and have Intervertebral disc protrusion?

- Check whether Intervertebral disc protrusion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Micro-k:

Micro-k (1,895 reports)

Browse all side effects of Micro-k:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Intervertebral disc protrusion:

Intervertebral disc protrusion (1,531 drugs)

Browse all the conditions that are associated with Intervertebral disc protrusion:

Intervertebral disc protrusion (1,305 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on potassium chloride (the active ingredients of Micro-k) and Micro-k (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.